319 related articles for article (PubMed ID: 31410338)
1. A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemo-radiotherapy-induced Oral Mucositis and Dysphagia in Patients with Oropharynx and Larynx Carcinoma.
Pathak S; Soni TP; Sharma LM; Patni N; Gupta AK
Cureus; 2019 Jun; 11(6):e4855. PubMed ID: 31410338
[TBL] [Abstract][Full Text] [Related]
2. Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine.
Pattanayak L; Panda N; Dash MK; Mohanty S; Samantaray S
J Glob Oncol; 2016 Aug; 2(4):200-206. PubMed ID: 28717702
[TBL] [Abstract][Full Text] [Related]
3. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
4. A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer.
Grover A; Soni TP; Patni N; Singh DK; Jakhotia N; Gupta AK; Sharma LM; Sharma S; Gothwal RS
Radiat Oncol J; 2021 Mar; 39(1):15-23. PubMed ID: 33794570
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
[TBL] [Abstract][Full Text] [Related]
6. Oral glutamine: Is there a role in the amelioration of radiation-induced mucositis? A prospective case-control study at a tertiary care centre in North India.
Fatima K; Andleeb A; Nasreen S; Sofi MA; Najmi AM; Qadri SK; Ryhan R; Roohi S; Afroz F; Khan NA
J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261438
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Achieving Dose Constraints for Dysphagia Aspiration-Related Structures and Its Clinical Significance in Intensity-Modulated Radiotherapy Planning of Head and Neck Cancer.
Agarwal K; Kumar P; S N; Kumar P; Garg A; Nigam J; N S S
Cureus; 2024 Feb; 16(2):e53769. PubMed ID: 38465172
[TBL] [Abstract][Full Text] [Related]
8. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
[TBL] [Abstract][Full Text] [Related]
9. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of the Toxicities in Patients With Locally Advanced Head and Neck Cancers Treated With Concomitant Boost Radiotherapy Versus Conventional Chemoradiation.
Sharma R; Vats S; Seam R; Gupta M; Negi RR; Fotedar V; Singh K
Cureus; 2023 Apr; 15(4):e38362. PubMed ID: 37266055
[TBL] [Abstract][Full Text] [Related]
11. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial.
Huang EY; Leung SW; Wang CJ; Chen HC; Sun LM; Fang FM; Yeh SA; Hsu HC; Hsiung CY
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):535-9. PubMed ID: 10701731
[TBL] [Abstract][Full Text] [Related]
12. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
14. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study.
Chattopadhyay S; Saha A; Azam M; Mukherjee A; Sur PK
South Asian J Cancer; 2014 Jan; 3(1):8-12. PubMed ID: 24665438
[TBL] [Abstract][Full Text] [Related]
15. Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.
Suhag V; Sunita BS; Vats P; Chakravarty N; Pandya T; Lohia N
Indian J Otolaryngol Head Neck Surg; 2019 Oct; 71(Suppl 1):192-198. PubMed ID: 31741959
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID 19 pandemic: A tertiary care experience.
Agarwal S; Jaiswal I; Shahi UP; Mandal A; Aggarwal LM; Singh A; Jaiswal A; Yadawa N
J Cancer Res Ther; 2024 Jan; 20(1):404-409. PubMed ID: 38554353
[TBL] [Abstract][Full Text] [Related]
17. Pre-radiotherapy Haemoglobin Level is A Prognosticator in Locally Advanced Head and Neck Cancers Treated with Concurrent Chemoradiation.
Narayanaswamy RK; Potharaju M; Vaidhyswaran AN; Perumal K
J Clin Diagn Res; 2015 Jun; 9(6):XC14-XC18. PubMed ID: 26266202
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
[TBL] [Abstract][Full Text] [Related]
19. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis.
Chitapanarux I; Tungkasamit T; Petsuksiri J; Kannarunimit D; Katanyoo K; Chakkabat C; Setakornnukul J; Wongsrita S; Jirawatwarakul N; Lertbusayanukul C; Sripan P; Traisathit P
Support Care Cancer; 2018 Mar; 26(3):879-886. PubMed ID: 28942587
[TBL] [Abstract][Full Text] [Related]
20. Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancer.
Lopez-Vaquero D; Gutierrez-Bayard L; Rodriguez-Ruiz JA; Saldaña-Valderas M; Infante-Cossio P
Mol Clin Oncol; 2017 Jun; 6(6):931-936. PubMed ID: 28588793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
